Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-03-11Clinical Trial Update: Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease [Phase 2]
Phase 2 trial update on piclozotan for motor complications in Parkinson's disease; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: Parkinson's Disease Therapy Using Cell Technology [Phase 2, Phase 3]
Phase 2/3 trial update for a Parkinson's disease therapy using mesenchymal stem cell transplantation.
-
CLINICAL_TRIALS trial_result · 2021-03-02Clinical Trial Update: Nabilone for Non-motor Symptoms in Parkinson's Disease [Phase 3]
Phase 3 trial evaluating nabilone for non-motor symptoms in Parkinson's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-02Clinical Trial Update: Nabilone for Non-motor Symptoms in Parkinson's Disease [Phase 2]
Phase 2 trial update on nabilone for non-motor symptoms in Parkinson's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: A Study to Determine the Dose of WIN-1001X by Evaluating Efficacy and Safety in Early Parkinson's Disease Patients [Phase 2]
Phase 2 clinical trial evaluating the dose of WIN-1001X for efficacy and safety in early Parkinson's disease.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: Dental Appliance for Parkinson's Disease [NA]
Clinical trial assessing a dental appliance for Parkinson's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease Subjects [Phase 2]
Phase 2 trial evaluating efficacy, safety, and pharmacokinetics of XP21279 with Sinemet in Parkinson's disease completed.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide)
Clinical trial update reporting outcomes assessment for Parkinson's disease patients treated with XADAGO (safinamide).
-
CLINICAL_TRIALS trial_result · 2021-02-17Clinical Trial Update: A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease. [Phase 2]
Phase 2 trial results for KDT-3594 in early Parkinson's disease have been completed.
-
CLINICAL_TRIALS trial_result · 2021-02-16Clinical Trial Update: The SUSTAIN Study Compares the Effects of Sustained and Immediate-release Pramipexole on the noctUrnal Symptoms of paTients With Advanced ParkInsoN's Disease Who Also Take L-Dopa [Phase 4]
A Phase 4 trial comparing sustained-release versus immediate-release pramipexole for nocturnal symptoms in advanced Parkinson disease patien…
-
CLINICAL_TRIALS trial_result · 2021-02-12Clinical Trial Update: Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease Experiments 1 & 2 - Proj #3 [Phase 2]
Phase 2 clinical trial update studying cholinergic mechanisms of gait dysfunction in Parkinson's disease; study completed with results poste…
-
FDA approval · 2021-02-09FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for carbidopa and levodopa from Sun Pharmaceutical Industries, expanding the approval for this g…
-
CLINICAL_TRIALS trial_result · 2021-02-08Clinical Trial Update: A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease [Phase 2]
Phase 2 results for prasinezumab (RO7046015/PRX002) in early Parkinson's disease have been posted.
-
FDA approval · 2021-02-04FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Carbidopa and Levodopa from Teva Pharmaceuticals USA, Inc., updating the product under the exist…
-
FDA approval · 2021-02-02FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for carbidopa and levodopa by Mylan Pharmaceuticals Inc., reflecting changes to an already approved …
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Crossover Target Engagement Study of Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease (Project #3 - Experiment 3 [UdallP3E3]) [Phase 2]
Phase 2 crossover study evaluating cholinergic target engagement for gait dysfunction in Parkinson's disease has completed with posted resul…
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Medication Responsiveness in Parkinson's Disease [Phase 2]
Phase 2 clinical trial completed evaluating medication responsiveness in Parkinson's disease, with focus on medication compliance and tappin…
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: Study of the Symptomatic Effects of Nocturnal Sodium Oxybate in Parkinson's Disease [Phase 2]
Phase 2 trial evaluating the symptomatic effects of nocturnal sodium oxybate in Parkinson's disease with sleep-wake disturbances completed.
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: Orthostatic Dysregulation and Associated Gastrointestinal Dysfunction in Parkinson's Disease -Treatment [Phase 2]
Phase 2 trial investigating orthostatic dysregulation and related GI dysfunction in Parkinson's disease has completed.
-
FDA label_change · 2021-01-19FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for bromocriptine mesylate from Zydus Pharmaceuticals USA Inc., resulting in labeling changes fo…
-
FDA approval · 2021-01-14FDA Approved: RASAGILINE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for Rasagiline submitted by Ascend Laboratories, LLC.
-
FDA approval · 2021-01-14FDA Approved: RASAGILINE MESYLATE — Supplemental Application (Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for Rasagiline Mesylate filed by Avet Pharmaceuticals, approving a generic version of the Parkin…
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: Asymmetric Subthalamic Deep Brain Stimulation for Axial Motor Dysfunction in Parkinson's Disease [NA]
Clinical trial update on asymmetric subthalamic deep brain stimulation for axial motor dysfunction in Parkinson's disease; study completed w…
-
CLINICAL_TRIALS trial_result · 2020-12-30Clinical Trial Update: The Stanford Parkinson's Disease Plasma Study [Phase 1]
Phase 1 clinical trial update for the Stanford Parkinson's Disease Plasma Study, with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-12-24Clinical Trial Update: Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease [Phase 2]
Phase 2 clinical trial update on AQW051 assessing safety and efficacy for L-dopa induced dyskinesias in Parkinson's disease.